共 36 条
- [31] How can misclassification be prevented when using the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria? Comment on the article by van der Linden et al ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2544 - 2546
- [32] How can misclassification be prevented when using the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria? Comment on the article by van der Linden et al Reply ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2546 - 2546
- [35] IMPACT OF BASELINE DEMOGRAPHICS, DISEASE ACTIVITY AND CONCOMITANT MEDICATION ON AMERICAN COLLEGE OF RHEUMATOLOGY 20 RESPONSE RATE AND HEALTH ASSESSMENT QUESTIONNAIRE-DISABILITY INDEX SCORE WITH TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS: A POOLED SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1585 - 1586
- [36] A quantitative continuous scale, ("majority percent improvement") of American College of Rheumatology (ACR) Core Data Set measures to extend information from categorical levels of "majority improvement" seen in ACR20 or 50 in subscales of "patient only", or "assessor (MD) only", and "combined patient and MD" measures. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S401 - S401